The company has leased 73,000 square feet at the forthcoming mixed-use community
Toro Development Company (TDC) today announced Boehringer Ingelheim, a leader in animal health innovation, has leased 73,000 square feet of lifestyle office space at Medley, the 43-acre mixed-use destination under construction in Johns Creek, Georgia. Medley, which is being developed on the site of a formerly defunct office campus, will become the new U.S. Animal Health headquarters for Boehringer Ingelheim and its almost 500 employees in Summer 2026.
The deal marks the largest new Class-A office lease north of the Perimeter in nearly five years, according to Stream Realty’s Bryan Heller and Parker Welton, who represented TDC. The sizable relocation reflects the “flight to energy” trend in office real estate.
“An active and energized mixed-use destination is the ultimate ‘people magnet’ for employers,” said Mark Toro, TDC’s Chief Vision Officer. “Medley’s fully amenitized and pedestrian-driven environment gives Boehringer Ingelheim a distinct competitive advantage as it seeks to recruit, retain and return the best and brightest in a setting that fosters innovation and collaboration.”
Heller added, “Medley fills a long-standing gap in Johns Creek’s office offering – a city that, while a demographic powerhouse and the envy of municipalities nationwide, has long lacked a vibrant, all-day destination that truly brings it all together.”
Boehringer Ingelheim will occupy two full floors of Medley’s lifestyle office building overlooking the shops and dining along Medley Boulevard. Boehringer Ingelheim’s space will be located within an existing building that is being renovated and seamlessly integrated with Medley’s walkable streets, best-in-class retail and restaurants and activated green spaces. Including the street-level retail, the reimagined office building encompasses 150,000 square feet.
“Medley will bring a new energy to Boehringer’s U.S. Animal Health headquarters. This is not just a new building; it’s a move that symbolizes our forward-thinking mentality and our commitment to animal health,” said Peter Ploeger, Country Managing Director for the U.S. Animal Health business at Boehringer Ingelheim. “Our goal is to develop a workplace that reflects our unwavering commitment to advance the health and well-being of animals and generates energy and pride within our employees.”
As Georgia’s Animal Health company, Boehringer has a large footprint in the state from manufacturing operations in Gainesville and Athens to the recent expansion of its global research and development building in Athens.
“Boehringer Ingelheim’s decision to invest in Fulton County reinforces our reputation as a premier destination for business and innovation,” said Robb Pitts, Chairman, Fulton County Board of Commissioners. “This major investment not only fuels job creation but also enhances our position as a leader in the life sciences industry.”
“We are excited for Boehringer Ingelheim to join our growing business community. Their selection of Johns Creek, the first municipality in the State of Georgia to be designated as a gold level BioReady® Community, furthers our reputation as a leader in health, wellness, and innovation,” said Johns Creek mayor John Bradberry. “This significant relocation is just the latest sign that Johns Creek is the place to be.”
TDC razed the site’s other existing, functionally obsolete office building to make way for Medley’s mixed-use experience. The two buildings were formerly home to State Farm, before it relocated its campus to Park Center, a mixed-use regional hub in Atlanta’s Perimeter. Boehringer Ingelheim will move into its new office next summer, ahead of Medley’s grand opening on October 29, 2026.
In addition to the office component, Medley will encompass 150,000 square feet of retail, restaurant and entertainment space, a 175-key boutique hotel, 750 multifamily residences, 133 for-sale townhomes and an activated 25,000-square-foot Plaza. TDC will infuse its signature approach to resort-style hospitality, entertainment and community building at Medley, which includes hosting approximately 200 events per year, ranging from outdoor wellness classes and live music to art festivals and watch parties.
Announced retailers for Medley include a specialty neighborhood grocer, Sephora, Rena’s Italian Fishery & Grill, High Country Outfitters, BODYROK, Playa Bowls, Petfolk, CRÚ Food & Wine Bar, Fadó Irish Pub, Summit Coffee, Lily Sushi Bar, Knuckies Hoagies, Cookie Fix, Sugarcoat Beauty, BODY20, AYA Medical Spa, 26 Thai Kitchen and Bar, Five Daughters Bakery, Drybar® Shops, Minnie Olivia Pizzeria, Burdlife, Amorino, Pause Studio, Fogón and Lions and Clean Your Dirty Face®.
Johns Creek is one of the top communities in the nation. Last year, the city was recognized by Travel + Leisure as the best suburb in the United States. Notably, Medley serves as an important part of Johns Creek’s 192-acre Town Center, which will weave together quality housing, restaurants, retail and offices through new public pathways and parks, furthering the walkable lifestyle for residents.
For the latest news and project updates, visit medleyjohnscreek.com and follow the project on Facebook, X and Instagram.
About Toro Development Company
At Toro Development Company, we believe past results are a powerful predictor of future success. Veteran real estate developer Mark Toro has a track record of delivering outsized returns to investors. His differentiated model combines data analysis with creative thinking and a commitment to community. With multidisciplinary experience, the team at Toro Development Company is uniquely positioned to deploy the best use or uses for each development, or redevelopment opportunity. They know how to build community in a way that creates quantifiable value, something they have proven over and over again, and something that is now more relevant than ever. For more information, visit www.torodevco.com.
About Boehringer Ingelheim – Animal Health business
Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society. Learn more at www.boehringer-ingelheim.com/
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.
